The biology of human natural killer-cell subsets - PubMed (original) (raw)
Review
The biology of human natural killer-cell subsets
M A Cooper et al. Trends Immunol. 2001 Nov.
Abstract
Human natural killer (NK) cells comprise approximately 15% of all circulating lymphocytes. Owing to their early production of cytokines and chemokines, and ability to lyse target cells without prior sensitization, NK cells are crucial components of the innate immune system. Human NK cells can be divided into two subsets based on their cell-surface density of CD56--CD56(bright) and CD56(dim)--each with distinct phenotypic properties. Now, there is ample evidence to suggest that these NK-cell subsets have unique functional attributes and, therefore, distinct roles in the human immune response. The CD56(dim) NK-cell subset is more naturally cytotoxic and expresses higher levels of Ig-like NK receptors and FCgamma receptor III (CD16) than the CD56(bright) NK-cell subset. By contrast, the CD56(bright) subset has the capacity to produce abundant cytokines following activation of monocytes, but has low natural cytotoxicity and is CD16(dim) or CD16(-). In addition, we will discuss other cell-surface receptors expressed differentially by human NK-cell subsets and the distinct functional properties of these subsets.
Similar articles
- CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.
Juelke K, Killig M, Luetke-Eversloh M, Parente E, Gruen J, Morandi B, Ferlazzo G, Thiel A, Schmitt-Knosalla I, Romagnani C. Juelke K, et al. Blood. 2010 Aug 26;116(8):1299-307. doi: 10.1182/blood-2009-11-253286. Epub 2010 May 26. Blood. 2010. PMID: 20505160 - New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
Pesce S, Squillario M, Greppi M, Loiacono F, Moretta L, Moretta A, Sivori S, Castagnola P, Barla A, Candiani S, Marcenaro E. Pesce S, et al. Front Immunol. 2018 Oct 15;9:2360. doi: 10.3389/fimmu.2018.02360. eCollection 2018. Front Immunol. 2018. PMID: 30374356 Free PMC article. - Role of chemokines in the biology of natural killer cells.
Maghazachi AA. Maghazachi AA. Curr Top Microbiol Immunol. 2010;341:37-58. doi: 10.1007/82_2010_20. Curr Top Microbiol Immunol. 2010. PMID: 20369317 Review. - Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56brightCD16+NKp80+/-In-Vitro and Express KIR2DL2/DL3 and KIR3DL1.
Euchner J, Sprissler J, Cathomen T, Fürst D, Schrezenmeier H, Debatin KM, Schwarz K, Felgentreff K. Euchner J, et al. Front Immunol. 2021 May 4;12:640672. doi: 10.3389/fimmu.2021.640672. eCollection 2021. Front Immunol. 2021. PMID: 34017328 Free PMC article. - CD56bright natural killer (NK) cells: an important NK cell subset.
Poli A, Michel T, Thérésine M, Andrès E, Hentges F, Zimmer J. Poli A, et al. Immunology. 2009 Apr;126(4):458-65. doi: 10.1111/j.1365-2567.2008.03027.x. Immunology. 2009. PMID: 19278419 Free PMC article. Review.
Cited by
- Three-Dimensional Model Analysis Revealed Differential Cytotoxic Effects of the NK-92 Cell Line and Primary NK Cells on Breast and Ovarian Carcinoma Cell Lines Mediated by Variations in Receptor-Ligand Interactions and Soluble Factor Profiles.
Alekseeva NA, Boyko AA, Shevchenko MA, Grechikhina MV, Streltsova MA, Alekseeva LG, Sapozhnikov AM, Deyev SM, Kovalenko EI. Alekseeva NA, et al. Biomedicines. 2024 Oct 20;12(10):2398. doi: 10.3390/biomedicines12102398. Biomedicines. 2024. PMID: 39457710 Free PMC article. - Dysregulation of immunity in COVID-19 and SLE.
Hejazian SS, Hejazian SM, Farnood F, Abedi Azar S. Hejazian SS, et al. Inflammopharmacology. 2022 Oct;30(5):1517-1531. doi: 10.1007/s10787-022-01047-2. Epub 2022 Aug 26. Inflammopharmacology. 2022. PMID: 36028612 Free PMC article. Review. - Sialylation of Human Natural Killer (NK) Cells is Regulated by IL-2.
Rosenstock P, Bork K, Massa C, Selke P, Seliger B, Horstkorte R. Rosenstock P, et al. J Clin Med. 2020 Jun 11;9(6):1816. doi: 10.3390/jcm9061816. J Clin Med. 2020. PMID: 32545211 Free PMC article. - Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.
Pace M, Williams J, Kurioka A, Gerry AB, Jakobsen B, Klenerman P, Nwokolo N, Fox J, Fidler S, Frater J; CHERUB Investigators. Pace M, et al. PLoS Pathog. 2016 Aug 16;12(8):e1005782. doi: 10.1371/journal.ppat.1005782. eCollection 2016 Aug. PLoS Pathog. 2016. PMID: 27529554 Free PMC article. - Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions.
Zhong Y, Liu J. Zhong Y, et al. Cell Death Discov. 2024 Jul 10;10(1):318. doi: 10.1038/s41420-024-02077-1. Cell Death Discov. 2024. PMID: 38987565 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials